MIFEPREX

LOE Approaching

mifepristone

NDAORALTABLETPriority Review
Approved
Sep 2000
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15

Clinical Trials (5)

NCT06099769Phase 2Recruiting

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

Started Oct 2023
201 enrolled
Metastatic Breast Cancer
NCT05772169Phase 4Completed

Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST)

Started Mar 2023
1,113 enrolled
HypercortisolismDiabetes Mellitus, Type 2
NCT04588688Phase 2Terminated

Mifepristone Dynamic Testing for Diagnosis for Central Adrenal Insufficiency

Started May 2021
3 enrolled
Central Adrenal InsufficiencyMifepristone
NCT03258372Phase 1Completed

Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites

Started Aug 2017
48 enrolled
Healthy
NCT03259542Phase 1Completed

Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor

Started Aug 2017
33 enrolled
Drug Interaction PotentiationHealthy